These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19519587)

  • 1. New applications for sublingual immunotherapy in allergy.
    Incorvaia C; Mauro M; Cappelletti T; Pravettoni C; Leo G; Riario-Sforza GG
    Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):113-7. PubMed ID: 19519587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of allergen-specific immunotherapy (desensitization) for the treatment of allergies in Germany. Current situation].
    Kleine-Tebbe J; Ackermann-Simon J; Hanf G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):343-50. PubMed ID: 22373847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous Immunotherapy and Sublingual Immunotherapy: Comparative Efficacy, Current and Potential Indications, and Warnings--United States Versus Europe.
    Nelson HS; Makatsori M; Calderon MA
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):13-24. PubMed ID: 26617224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local immunotherapy in allergy.
    Morris DL; Kroker GF; Sabnis VK; Morris MS
    Chem Immunol Allergy; 2003; 82():1-10. PubMed ID: 12947987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual immunotherapy: other indications.
    Passalacqua G; Compalati E; Canonica GW
    Immunol Allergy Clin North Am; 2011 May; 31(2):279-87, ix. PubMed ID: 21530820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
    Richards JR; Stumpf JL
    Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for house-dust mite allergy.
    Nelson HS
    Allergy Asthma Proc; 2018 Jul; 39(4):264-272. PubMed ID: 30095391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
    Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of SQ house dust mite (HDM) SLIT-tablet treatment of HDM allergic asthma.
    Canonica GW; Virchow JC; Zieglmayer P; Ljørring C; Smith IM; Mosbech H
    Expert Rev Clin Immunol; 2016 Aug; 12(8):805-15. PubMed ID: 27322777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age and indications to SLIT.
    Terracciano L; Calcinai E; Avitabile S; Galli E
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):5-8. PubMed ID: 19944002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison study of subcutaneous immunotherapy and sublingual immunotherapy in patients with allergic rhinitis].
    You SH; Qin XY; Xu C; Qiu X; Luan ZL; Jia HX; Wang HT
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):689-693. PubMed ID: 29771014
    [No Abstract]   [Full Text] [Related]  

  • 13. Subcutaneous and sublingual allergen-specific immunotherapy: a tale of two routes.
    Incorvaia C; Ciprandi G; Nizi MC; Makri E; Ridolo E
    Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):245-257. PubMed ID: 32372588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One century of allergen-specific immunotherapy for respiratory allergy.
    Incorvaia C; Frati F
    Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
    Mascarell L; Van Overtvelt L; Moingeon P
    Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of sublingual immunotherapy in grass pollen allergy.
    Wessner D; Rakoski J; Ring J
    Chem Immunol Allergy; 2003; 82():53-61. PubMed ID: 12947992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of respiratory allergy with allergy immunotherapy tablets.
    Bachert C
    Allergy; 2011 Jul; 66 Suppl 95():57-9. PubMed ID: 21668858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Applications of Sublingual Immunotherapy.
    Edwards TS; Wise SK
    Otolaryngol Clin North Am; 2017 Dec; 50(6):1121-1134. PubMed ID: 29103453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.